Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Clinical trial NCT00005958 · UNKNOWN

Trial details

NCT number: NCT00005958
Sponsor: Amgen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter

Start date: 1999-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.